P3 Health Partners (PIII) to Release Quarterly Earnings on Thursday

Key Points

• P3 Health Partners is expected to release its Q2 2025 earnings on August 6, with analysts predicting a loss of ($3.29) per share and revenue of $356.52 million.
• In the last quarterly report, the company reported ($6.28) earnings per share, missing estimates by ($1.28), despite exceeding revenue expectations with $373.23 million.
• Analysts have revised the price target for P3 Health Partners from $50.00 to $20.00, maintaining a "buy" rating.

P3 Health Partners (NASDAQ:PIII - Get Free Report) will likely be releasing its Q2 2025 earnings data after the market closes on Thursday, August 14th. Analysts expect the company to announce earnings of ($3.29) per share and revenue of $356.52 million for the quarter.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last announced its quarterly earnings data on Thursday, May 15th. The company reported ($6.28) EPS for the quarter, missing analysts' consensus estimates of ($5.00) by ($1.28). P3 Health Partners had a negative net margin of 9.27% and a negative return on equity of 123.10%. The business had revenue of $373.23 million during the quarter, compared to analysts' expectations of $362.09 million. On average, analysts expect P3 Health Partners to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

P3 Health Partners Trading Down 0.9%

PIII stock traded down $0.07 during trading on Friday, reaching $7.35. 6,161 shares of the stock traded hands, compared to its average volume of 12,072. The business's 50 day moving average price is $6.62 and its 200-day moving average price is $8.33. P3 Health Partners has a 52-week low of $5.80 and a 52-week high of $32.54. The company has a debt-to-equity ratio of 1.68, a current ratio of 0.38 and a quick ratio of 0.38. The firm has a market capitalization of $52.83 million, a PE ratio of -0.16 and a beta of 0.78.

Analyst Ratings Changes

Separately, Lake Street Capital cut their price objective on P3 Health Partners from $50.00 to $20.00 and set a "buy" rating on the stock in a research note on Monday, April 21st.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.